Glenmede Trust’s Amgen AMGN Stock Holding History

Glenmede Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.7M	Sell	127,157 -1,319	-1%	-$470K	0.22%	87
2025 Q4	$42.1M	Buy	+128,476	New	+$40.8M	0.2%	94
2025 Q1	$36.1M	Sell	115,889 -2,658	-2%	-$785K	0.19%	110
2024 Q4	$30.9M	Sell	118,547 -71,848	-38%	-$21.3M	0.16%	124
2024 Q3	$61.3M	Sell	190,395 -42,532	-18%	-$13.9M	0.29%	80
2024 Q2	$72.8M	Sell	232,927 -62,372	-21%	-$18.3M	0.37%	67
2024 Q1	$84M	Sell	295,299 -17,113	-5%	-$5.01M	0.42%	56
2023 Q4	$90M	Sell	312,412 -41,396	-12%	-$11.3M	0.47%	47
2023 Q3	$95.1M	Sell	353,808 -5,455	-2%	-$1.36M	0.54%	39
2023 Q2	$86.8M	Sell	359,263 -147	-0%	-$34.1K	0.49%	48
2023 Q1	$86.9M	Sell	359,410 -1,302	-0.4%	-$320K	0.49%	48
2022 Q4	$94.7M	Sell	360,712 -31,750	-8%	-$8.51M	0.56%	37
2022 Q3	$88.5M	Buy	392,462 +7,103	+2%	+$1.72M	0.56%	37
2022 Q2	$93.8M	Sell	385,359 -27,704	-7%	-$6.79M	0.55%	38
2022 Q1	$99.9M	Sell	413,063 -34,648	-8%	-$7.96M	0.49%	45
2021 Q4	$101M	Buy	447,711 +9,638	+2%	+$2.03M	0.48%	45
2021 Q3	$93.2M	Buy	438,073 +957	+0.2%	+$220K	0.48%	44
2021 Q2	$107M	Sell	437,116 -73,313	-14%	-$18M	0.55%	37
2021 Q1	$127M	Sell	510,429 -72,805	-12%	-$17.4M	0.68%	24
2020 Q4	$134M	Buy	583,234 +305	+0.1%	+$70.3K	0.74%	21
2020 Q3	$148M	Sell	582,929 -27,294	-4%	-$6.76M	0.89%	16
2020 Q2	$144M	Sell	610,223 -180,497	-23%	-$41.2M	0.88%	16
2020 Q1	$191M	Hold	790,720	–	–	0.87%	19
2019 Q4	$191M	Sell	790,720 -1,661	-0.2%	-$366K	0.87%	19
2019 Q3	$153K	Sell	792,381 -32,367	-4%	-$6.21M	0.7%	23
2019 Q2	$152K	Buy	824,748 +9,731	+1%	+$1.74M	0.67%	27
2019 Q1	$155K	Sell	815,017 -2,114	-0.3%	-$404K	0.7%	25
2018 Q4	$159K	Sell	817,131 -78,503	-9%	-$15.3M	0.78%	17
2018 Q3	$186M	Sell	895,634 -42,827	-5%	-$8.44M	0.74%	15
2018 Q2	$173M	Sell	938,461 -62,219	-6%	-$11M	0.77%	19
2018 Q1	$174M	Hold	1,000,680	–	–	0.73%	16
2017 Q4	$174M	Buy	1,000,680 +36,618	+4%	+$6.48M	0.73%	16
2017 Q3	$180M	Buy	964,062 +45,604	+5%	+$8.08M	0.79%	11
2017 Q2	$151M	Hold	918,458	–	–	0.72%	14
2017 Q1	$151M	Sell	918,458 -3,342	-0.4%	-$555K	0.72%	14
2016 Q4	$135M	Buy	921,800 +75,632	+9%	+$11.4M	0.73%	16
2016 Q3	$141M	Buy	846,168 +90,817	+12%	+$15.4M	0.8%	13
2016 Q2	$115M	Buy	755,351 +4,642	+0.6%	+$722K	0.7%	16
2016 Q1	$113M	Buy	750,709 +78,547	+12%	+$11.7M	0.73%	16
2015 Q4	$109M	Buy	672,162 +18,059	+3%	+$2.84M	0.74%	15
2015 Q3	$90.5M	Buy	654,103 +39,942	+7%	+$6.3M	0.66%	18
2015 Q2	$94.3M	Buy	614,161 +51,609	+9%	+$8.27M	0.68%	16
2015 Q1	$89.9M	Buy	562,552 +104,246	+23%	+$16.4M	0.66%	19
2014 Q4	$73M	Buy	458,306 +41,533	+10%	+$6.47M	0.57%	28
2014 Q3	$58.5M	Buy	416,773 +52,478	+14%	+$6.85M	0.51%	37
2014 Q2	$43.1M	Buy	364,295 +74,956	+26%	+$8.68M	0.39%	52
2014 Q1	$35.7M	Buy	289,339 +3,513	+1%	+$426K	0.33%	62
2013 Q4	$32.6M	Sell	285,826 -37,571	-12%	-$4.27M	0.33%	63
2013 Q3	$36.2M	Sell	323,397 -7,730	-2%	-$838K	0.43%	51
2013 Q2	$32.7M	Buy	+331,127	New	+$34.4M	0.41%	54

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Glenmede Trust's AMGN Position: Q1 2026 in Review

Glenmede Trust reduced its Amgen (AMGN) stake by 1% in Q1 2026, selling an estimated $470K and leaving 127,157 shares worth $44.7M. The position accounts for 0.22% of the portfolio, ranked #87.

Glenmede Trust first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $191M in Q1 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Glenmede Trust held 127,157 shares of Amgen worth $44.7M as of Q1 2026.
Glenmede Trust sold 1,319 Amgen shares in Q1 2026, an estimated $470K.
Amgen made up 0.22% of Glenmede Trust's portfolio in Q1 2026, its #87 holding.
Glenmede Trust first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
Glenmede Trust's Amgen position peaked at $191M in Q1 2020.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.